Jeffrey Livezey

1.4k total citations
26 papers, 570 citations indexed

About

Jeffrey Livezey is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, Jeffrey Livezey has authored 26 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Pharmacology and 5 papers in Epidemiology. Recurrent topics in Jeffrey Livezey's work include Poisoning and overdose treatments (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Jeffrey Livezey is often cited by papers focused on Poisoning and overdose treatments (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Jeffrey Livezey collaborates with scholars based in United States, Thailand and Kenya. Jeffrey Livezey's co-authors include Isabell A. Sesterhenn, Vasantha Srikantan, David G. McLeod, Judd W. Moul, Shiv Srivastava, Leland Davis, Kiyoshi Yoshino, Linda Xu, Zhiqiang Zou and György Petrovics and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Infectious Diseases and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Jeffrey Livezey

26 papers receiving 550 citations

Peers

Jeffrey Livezey

EDM

PRM

EPIDE

Tobias Weissenbacher Germany

Haiying Yan China

Xingcheng Xiong China

Claudia Schurmann Germany

Jiarui Feng China

Yuko Tanaka Japan

Shu Xia China

Aslı Teti̇k Vardarli Türkiye

Fenghua Peng China

Jeong Hee Hong South Korea

Tobias Weissenbacher Germany

Jeffrey Livezey

165 ×0.5

160 ×0.7

25 ×0.3

EDM

70 ×0.8

PRM

81 ×1.6

EPIDE

Citations per year, relative to Jeffrey Livezey Jeffrey Livezey (= 1×) peers Tobias Weissenbacher

Countries citing papers authored by Jeffrey Livezey

Since Specialization

Citations

This map shows the geographic impact of Jeffrey Livezey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Livezey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Livezey more than expected).

Fields of papers citing papers by Jeffrey Livezey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Livezey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Livezey. The network helps show where Jeffrey Livezey may publish in the future.

Co-authorship network of co-authors of Jeffrey Livezey

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Livezey. A scholar is included among the top collaborators of Jeffrey Livezey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Livezey. Jeffrey Livezey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chaudhury, Sidhartha, et al.. (2025). Identification of clinically relevant multi-drug resistant ESKAPEE isolates from hospital wastewater surveillance in Thailand. Frontiers in Microbiology. 16. 1657219–1657219. 1 indexed citations

Hooper, Jay W., Steven A. Kwilas, Matthew Josleyn, et al.. (2024). Phase 1 clinical trial of Hantaan and Puumala virus DNA vaccines delivered by needle-free injection. npj Vaccines. 9(1). 221–221. 4 indexed citations

Anothaisintawee, Thunyarat, et al.. (2023). Efficacy of drug treatment for severe melioidosis and eradication treatment of melioidosis: A systematic review and network meta-analysis. PLoS neglected tropical diseases. 17(6). e0011382–e0011382. 3 indexed citations

Khamadi, Samoel, Emmanuel Bahemana, Nicole Dear, et al.. (2023). Factors Associated With Viral Suppression and Drug Resistance in Children and Adolescents Living With HIV in Care and Treatment Programs in Southern Tanzania. Journal of the Pediatric Infectious Diseases Society. 12(6). 353–363. 11 indexed citations

Anothaisintawee, Thunyarat, et al.. (2023). Prevalence of Intestinal Parasitic Infections, Genotypes, and Drug Susceptibility of Giardia lamblia among Preschool and School-Aged Children: A Cross-Sectional Study in Thailand. Tropical Medicine and Infectious Disease. 8(8). 394–394. 3 indexed citations

Akers, Kevin S., et al.. (2022). Comparison of Piperacillin and Tazobactam Pharmacokinetics in Critically Ill Patients with Trauma or with Burn. Antibiotics. 11(5). 618–618. 8 indexed citations

Chung, Kevin K., et al.. (2022). Pharmacokinetics of piperacillin and tazobactam in critically Ill patients treated with continuous kidney replacement therapy: A mini‐review and population pharmacokinetic analysis. Journal of Clinical Pharmacy and Therapeutics. 47(8). 1091–1102. 8 indexed citations

Bobrov, Alexander G., Derese Getnet, Jeffrey Livezey, et al.. (2021). Semimechanistic Modeling of the Effects of Blast Overpressure Exposure on Cefazolin Pharmacokinetics in Mice. Journal of Pharmacology and Experimental Therapeutics. 379(2). 175–181. 2 indexed citations

Por, Elaine D., et al.. (2021). Population Pharmacokinetic Modeling and Simulations of Imipenem in Burn Patients With and Without Continuous Venovenous Hemofiltration in the Military Health System. The Journal of Clinical Pharmacology. 61(9). 1182–1194. 10 indexed citations

10.

Oliver, Thomas, et al.. (2021). Applying Pharmacogenomic Guidelines to Combat Medical Care. Military Medicine. 187(Supplement_1). 18–24. 1 indexed citations

11.

Por, Elaine D., et al.. (2021). Evaluation of Pharmacogenomics Testing of Cytochrome P450 Enzymes in the Military Health System From 2015 to 2020. Military Medicine. 187(Supplement_1). 1–8. 3 indexed citations

12.

Livezey, Jeffrey, et al.. (2021). Prescription Patterns and Relationship to Pharmacogenomics Testing in the Military Health System. Military Medicine. 187(Supplement_1). 9–17. 4 indexed citations

13.

Li, Qigui, et al.. (2020). Saccharomyces boulardii CNCM I-745 probiotic does not alter the pharmacokinetics of amoxicillin. Drug Metabolism and Personalized Therapy. 0(0). 2 indexed citations

14.

Livezey, Jeffrey, et al.. (2019). Toward Personalized Medicine Implementation: Survey of Military Medicine Providers in the Area of Pharmacogenomics. Military Medicine. 185(3-4). 336–340. 9 indexed citations

15.

Livezey, Jeffrey, Thomas Oliver, & Louis R. Cantilena. (2016). Prolonged Neuropsychiatric Symptoms in a Military Service Member Exposed to Mefloquine. PubMed. 3(1). 7–7. 7 indexed citations

16.

Straight, Timothy M., Gerald A. Merrill, L. Perez, et al.. (2010). A novel electrochemical device to differentiate pandemic (H1N1) 2009 from seasonal influenza. Influenza and Other Respiratory Viruses. 4(2). 73–79. 5 indexed citations

17.

Livezey, Jeffrey, Cydney Fenton, Aneeta Patel, et al.. (2005). BRAF Mutations are Uncommon in Papillary Thyroid Cancer of Young Patients. Thyroid. 15(4). 320–325. 100 indexed citations

18.

McCardell, B. A., Venugopal Sathyamoorthy, Jane M. Michalski, et al.. (2002). Cloning, expression and characterization of the CHO cell elongating factor (Cef) from Vibrio cholerae O1. Microbial Pathogenesis. 32(4). 165–172. 5 indexed citations

19.

Srikantan, Vasantha, Zhiqiang Zou, György Petrovics, et al.. (2000). PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proceedings of the National Academy of Sciences. 97(22). 12216–12221. 277 indexed citations

20.

Srikantan, Vasantha, Isabell A. Sesterhenn, Leland Davis, et al.. (1999). Allelic loss on chromosome 6Q in primary prostate cancer. International Journal of Cancer. 84(3). 331–335. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact